Cargando…
Change in mRNA Expression after Atenolol, a Beta-adrenergic Receptor Antagonist and Association with Pharmacological Response
AIMS: Genetic determinants of variability in response to β-blockers are poorly characterized. We defined changes in mRNA expression after a β-blocker to identify novel genes that could affect response and correlated these with inhibition of exercise-induced tachycardia, a measure of β-blocker sensit...
Autores principales: | Kohli, Utkarsh, Grayson, Britney L, Aune, Thomas M, Ghimire, Laxmi V, Kurnik, Daniel, Stein, C Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Inc
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773526/ https://www.ncbi.nlm.nih.gov/pubmed/19915711 http://dx.doi.org/10.1111/j.1753-5174.2009.00020.x |
Ejemplares similares
-
GENETIC VARIATION IN THE α(1A)-ADRENERGIC RECEPTOR AND PHENYLEPHRINE-MEDIATED VENOCONSTRICTION
por: Adefurin, Abiodun, et al.
Publicado: (2014) -
GENETIC VARIATION IN THE ALPHA(1B) - ADRENERGIC RECEPTOR AND VASCULAR RESPONSE
por: Adefurin, Abiodun, et al.
Publicado: (2016) -
Does atenolol differ from other β-adrenergic blockers?
por: Aursnes, Ivar, et al.
Publicado: (2007) -
Beta adrenergic antagonists and antianginal drugs
por: Stever, Lindsey M., et al.
Publicado: (2021) -
Beta-adrenergic receptor antagonists and chronic heart failure in children
por: Filippo, Sylvie Di
Publicado: (2007)